HIV integrase inhibitor Dolutegravir sodium, Purity ≥98%

Cat. No.: X24-07-ZQ045

HIV integrase inhibitor Dolutegravir sodium, Purity ≥98%

Synonym: 1051375-19-9; HIV integrase inhibitor; DTG; GSK1349572

  • MDL: MFCD28405599
  • CAS Number: 1051375-19-9
  • Compound CID: 46216142
Product Size
5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Dolutegravir sodium, soluble in DMSO and insoluble in ethanol and water, blocks the action of the integrase enzyme, which is crucial for the HIV virus to integrate its genetic material into the host cell’s DNA, thereby impeding the virus’s ability to replicate and spread. It targets HIV integrase.
Molecular Weight
441.36
Molecular Formula
C20H18F2N3NaO5
Targets
HIV integrase: 2.7 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 0.18 mg/mL (0.41 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
Dolutegravir sodium is utilized in research to inhibit HIV integrase, a key enzyme for the integration of viral DNA into the host genome, thus playing a crucial role in the treatment of HIV-1 infection.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0